TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06385782 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04948333 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04948333 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05453591 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05453591 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01582438 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05471271 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04684589 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT06242418 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04860778 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06558188 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06339879 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04976907 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04976907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04768608 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04768608 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05269394 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05435443 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06239467 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04980144 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06238713 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT06050330 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06050330 — Predictive Biomarker (PRD): S100A7 mRNA
Genes: S100A7; PSOR1; S100A7C
Study NCT05835310 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT05358379 — Predictive Biomarker (PRD): PLK1 mRNA
Genes: PLK1; PLK
Study NCT05997303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04776655 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04776655 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05818657 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05600062 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT06204835 — Predictive Biomarker (PRD): ITGA6 mRNA
Genes: ITGA6
Study NCT04881123 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06524999 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05066932 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06348108 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05395598 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04913129 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04913129 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05208684 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06178601 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05828329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05642910 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04952935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05624463 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06152822 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05160935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04638725 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04638725 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05689580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05689580 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT05547204 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT04986956 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04986956 — Safety Biomarker (SAF): BDNF
Study NCT05770323 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06520098 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06155396 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06501703 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT06112769 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06676982 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06715124 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05354323 — Predictive Biomarker (PRD): NEO1 mRNA
Genes: NEO1; IGDCC2; NGN
Study NCT05458336 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06278441 — Predictive Biomarker (PRD): HSPA5 mRNA
Genes: HSPA5; GRP78
Study NCT05191459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05191459 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06762886 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04951635 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04951635 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06241391 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06208475 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT06454617 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05139225 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05139225 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study NCT05156021 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05156021 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05167643 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05167643 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05167643 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05009407 — Predictive Biomarker (PRD): CD160 mRNA
Genes: CD160; BY55
Study NCT06333899 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT06333899 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06333899 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06501417 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT06501417 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT06501417 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study NCT06501417 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06436885 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05633342 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05653778 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT05429138 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05824975 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT05844150 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05574413 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05082701 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05617625 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05159323 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05159323 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05519735 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04197219 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00538811 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05114057 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05239988 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04711200 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06318533 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05842564 — Predictive Biomarker (PRD): ATG16L1 mRNA
Genes: ATG16L1; APG16L; UNQ9393/PRO34307
Study NCT05842564 — Predictive Biomarker (PRD): IRGM mRNA
Genes: IRGM; IFI1; IRGM1; LRG47
Study NCT05842564 — Predictive Biomarker (PRD): CALCOCO2 mRNA
Genes: CALCOCO2; NDP52
Study NCT05561556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05561556 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05932433 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT05532722 — Predictive Biomarker (PRD): KLRG1 mRNA
Genes: KLRG1; CLEC15A; MAFA; MAFAL
Study NCT06515210 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT06459869 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05751564 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00468962 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study NCT06027957 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04702919 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT05871177 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06032325 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05299632 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06084871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05163626 — Pharmacodynamic Biomarker (PDY): Neuromodulin
Genes: GAP43
Study NCT05163626 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT05345925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04980092 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT06056752 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05526027 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06167811 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06167811 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04708249 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05790265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05982587 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT04866680 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04708236 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06168331 — Predictive Biomarker (PRD): PAPOLB mRNA
Genes: PAPOLB; PAPT
Study NCT06168331 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05870943 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04901689 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04901689 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study NCT05788731 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04703361 — Predictive Biomarker (PRD): HCAR2 mRNA
Genes: HCAR2; GPR109A; HCA2; HM74A; NIACR1
Study NCT05756257 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05445934 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05650918 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05356325 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05949541 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05949541 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04495608 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT05227755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04984759 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT06381154 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06729931 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06729931 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT06731322 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06731322 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06731036 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06729970 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT06478394 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06730880 — Predictive Biomarker (PRD): IRF6 mRNA
Genes: IRF6
Study NCT05135715 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05433285 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05008900 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05038735 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05038735 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06730750 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04848194 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT05244135 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01240928 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05751941 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT05751941 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT05627570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00431925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00431925 — Safety Biomarker (SAF): Interleukin 1
Study NCT00431925 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06192199 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01909414 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06201507 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT03882307 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05996952 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04873960 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00000645 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05533580 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04799808 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05386108 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05630001 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04981405 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05254977 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04208529 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06419114 — Predictive Biomarker (PRD): PPL mRNA
Genes: PPL; KIAA0568
Study NCT06265272 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06520189 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05025826 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04946175 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04821583 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT05731349 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05333029 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06071585 — Predictive Biomarker (PRD): CCL26 mRNA
Genes: CCL26; SCYA26; UNQ216/PRO242
Study NCT06071585 — Predictive Biomarker (PRD): TBX5 mRNA
Genes: TBX5
Study NCT06071585 — Predictive Biomarker (PRD): NOX4 mRNA
Genes: NOX4; RENOX
Study NCT06071585 — Predictive Biomarker (PRD): FGF7 mRNA
Genes: FGF7; KGF
Study NCT06071585 — Predictive Biomarker (PRD): CXCL14 mRNA
Genes: CXCL14; MIP2G; NJAC; SCYB14; PSEC0212; UNQ240/PRO273
Study NCT06071585 — Predictive Biomarker (PRD): ADAMTS5 mRNA
Genes: ADAMTS5; ADAMTS11; ADMP2
Study NCT06071585 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT06071585 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT06071585 — Predictive Biomarker (PRD): ACVRL1 mRNA
Genes: ACVRL1; ACVRLK1; ALK1
Study NCT06071585 — Predictive Biomarker (PRD): POSTN mRNA
Genes: POSTN; OSF2
Study NCT06071585 — Predictive Biomarker (PRD): LTBP4 mRNA
Genes: LTBP4
Study NCT05614947 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05809531 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06432309 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT04220086 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT06503510 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT06675552 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04662255 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06618872 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06151730 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06151730 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05823727 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06686394 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06717438 — Predictive Biomarker (PRD): PPP2R5D mRNA
Genes: PPP2R5D
Study NCT06715943 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT06762834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05995249 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06347445 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06763159 — Predictive Biomarker (PRD): CDH6 mRNA
Genes: CDH6
Study NCT06471192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06471192 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06762808 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05083637 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT05541614 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT05541614 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05380882 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06051734 — Predictive Biomarker (PRD): ATP7B mRNA
Genes: ATP7B; PWD; WC1; WND
Study NCT05689931 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04201808 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04890041 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05510505 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05616325 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06181786 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT06036589 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT06764277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06764186 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06764186 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06764186 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06764186 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06764186 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT06764186 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05317117 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05065411 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05065411 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05065411 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04825496 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06506422 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05666531 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04991051 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT04895150 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05283512 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05283512 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06332365 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05646758 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04748055 — Safety Biomarker (SAF): Interleukin 1
Study NCT05599802 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04945421 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05751174 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06517030 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05928546 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05262829 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05539300 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05539300 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00002266 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT05330247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06226857 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05152940 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2